Literature DB >> 7891794

Progression of cerebral atrophy in patients on regular hemodialysis treatment: long-term follow-up with cerebral computed tomography.

G M Savazzi1, F Cusmano, S Vinci, L Allegri.   

Abstract

Fifteen patients (10 males, 5 females) on regular hemodialysis treatment (average age 43.6 +/- 4.0 years, average time on dialysis 100.7 +/- 62.8 months) underwent cerebral computed tomography between 1981 and 1984. Ten patients showed mild cerebral atrophy (CA) on the basis of cortical sulci exceeding 3 mm in breadth and an Evans ratio exceeding 0.31, for a total of 14 degrees of CA (mean 0.9 +/- 1). The same 15 patients underwent a second cerebral computed tomography during 1991/92 (101 +/- 23.7 months later). At that time, the patients exhibited a degree of CA of 2.6 +/- 1.4, for a total of 39 degrees with an overall increase of 25 degrees. Since CA is not detected before the age of 55 years in the normal population, we conclude that the CA in this patient group can only be attributed to uremia-related pathology and that it tends to worsen as regular hemodialysis treatment continues. Nevertheless, no evident cognitive, affective, or behavioural changes were verified in these patients. To our knowledge, this is the first presentation of radiologically documented progression of CA in the same patient population over time.

Entities:  

Mesh:

Year:  1995        PMID: 7891794     DOI: 10.1159/000188356

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

Review 1.  Adult chronic kidney disease: neurocognition in chronic renal failure.

Authors:  Nikhil S Koushik; Steven F McArthur; Anne D Baird
Journal:  Neuropsychol Rev       Date:  2009-08-25       Impact factor: 7.444

Review 2.  Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden.

Authors:  Anne M Murray
Journal:  Adv Chronic Kidney Dis       Date:  2008-04       Impact factor: 3.620

3.  Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease.

Authors:  Jianwei Dong; Xiaofen Ma; Wuhong Lin; Mengchen Liu; Shishun Fu; Lihua Yang; Guihua Jiang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-02       Impact factor: 2.570

Review 4.  "Is It Removed During Dialysis?"-Cognitive Dysfunction in Advanced Kidney Failure-A Review Article.

Authors:  Kirsty Crowe; Terence J Quinn; Patrick B Mark; Mark D Findlay
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

5.  Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.

Authors:  Kazuhiko Tsuruya; Hisako Yoshida; Naoki Haruyama; Kiichiro Fujisaki; Hideki Hirakata; Takanari Kitazono
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.